Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 12/20 | 0.52 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PIM1 | P11309 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30705750 | 0.78 | ERN1 (0.65) | ERN1PIM1 | |
| SCHEMBL5773682 | 0.77 | ERN1 (0.58) | ERN1PIM1 | |
| SCHEMBL8054676 | 0.77 | ERN1 (0.46) | ERN1LMNAMAPTPIM1 | |
| SCHEMBL14031706 | 0.77 | ERN1 (0.58) | ERN1MAPTPIM1 | |
| SCHEMBL210156 | 0.76 | ERN1 (0.69) | ERN1SRC | |
| SCHEMBL31612188 | 0.76 | ERN1 (0.69) | ERN1SRC | |
| SCHEMBL26857676 | 0.73 | ERN1 (0.54) | ERN1PIM1 | |
| SCHEMBL2921662 | 0.73 | ERN1 (0.54) | ERN1LMNAMAPT | |
| SCHEMBL13623366 | 0.72 | ERN1 (0.58) | ERN1SRCPIM1 | |
| SCHEMBL1176032 | 0.72 | SHBG (0.43) | SRCLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120117968-A | Process for preparing hydroxy-ortho-hydroxymethyl substituted methylene bridged substituted phenols and polyphenols containing multiple phenol units | 天津久日半导体材料有限公司 | 2025-06-10 | — | — | CN | disclosed |
| US-20070232839-A1 | NOVEL POLYNUCLEAR POLYPHENOL COMPOUND | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232839-A1 | NOVEL POLYNUCLEAR POLYPHENOL COMPOUND | TPR, PCNA, NCOA4 | ERN1 3435/4885SRC 2322/4885LMNA 2063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.